Literature DB >> 118937

Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms.

L Mathieu, P Chevalier, G Galy, M Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 118937     DOI： 10.1016/0020-708x(79)90150-9

Source DB:  PubMed          Journal:  Int J Appl Radiat Isot        ISSN： 0020-708X


× No keyword cloud information.
  7 in total

1.  A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone.

Authors:  J M O'Sullivan; A R Norman; V R McCready; G Flux; F M Buffa; B Johnson; J Coffey; G Cook; J Treleaven; A Horwich; R A Huddart; C C Parker; D P Dearnaley
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-30       Impact factor: 9.236

2.  Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases.

Authors:  W Y Lin; C P Lin; S J Yeh; B T Hsieh; Z T Tsai; G Ting; T C Yen; S J Wang; F F Knapp; M G Stabin
Journal:  Eur J Nucl Med       Date:  1997-06

Review 3.  186Re-HEDP for metastatic bone pain in breast cancer patients.

Authors:  Marnix G E H Lam; John M H de Klerk; Peter P van Rijk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-29       Impact factor: 9.236

4.  Samarium-153 EDTMP therapy of disseminated skeletal metastasis.

Authors:  J H Turner; A A Martindale; P Sorby; E L Hetherington; R F Fleay; R F Hoffman; P G Claringbold
Journal:  Eur J Nucl Med       Date:  1989

5.  Clinical utility of 188Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies.

Authors:  Ajit S Shinto; Madhava B Mallia; Mythili Kameswaran; K K Kamaleshwaran; Jephy Joseph; E R Radhakrishnan; Indira V Upadhyay; R Subramaniam; Madhu Sairam; Sharmila Banerjee; Ashutosh Dash
Journal:  World J Nucl Med       Date:  2018 Oct-Dec

6.  High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone.

Authors:  J M O'Sullivan; V R McCready; G Flux; A R Norman; F M Buffa; S Chittenden; M Guy; K Pomeroy; G Cook; J Gadd; J Treleaven; A Al-Deen; A Horwich; R A Huddart; D P Dearnaley
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

7.  Rhenium-188 Hydroxyethane 1,1-Diphosphonic Acid (HEDP) for Bone Pain Palliation Using BARC-HEDP Kits versus Pars-HEDP Kits: A Comparison on Preparation and Performance Aspects at Hospital Radiopharmacy.

Authors:  Radhakrishnan Edathuruthy Kalarickal Ramakurup; Viju Chirayil; Arun Pandiyan; Madhava Balakrishna Mallia; Mythili Kameswaran; Ajit Shinto; Ashutosh Dash
Journal:  Indian J Nucl Med       Date:  2018 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.